Lifecore Biomedical Inc (LFCR)

7.60 +0.57 (+8.11%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Lifecore Biomedical Research and Development Expense (Quarterly): 2.186M for Aug. 31, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for LFCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AngioDynamics Inc 6.285M
Precision Optics Corp Inc 0.4007M
Sage Therapeutics Inc 54.58M
Outset Medical Inc 8.139M
NovaBay Pharmaceuticals Inc 0.004M